logo
Share SHARE
FONT-SIZE Plus   Neg

Tranzyme Pharma Says That First Phase 3 Pivotal Trial Of Ulimorelin Failed

Late-stage biopharmaceutical company Tranzyme Pharma (TZYM), on Monday, along with specialty pharmaceutical company Norgine B.V., announced top-line results of the primary analysis of ULISES 007, the first of two Phase 3 pivotal trials evaluating ulimorelin.

The company stated that the trial failed to meet its primary and secondary efficacy endpoints.

Tranzyme further stated that the results of ULISES 007 showed that ulimorelin, at both 160 and 480 micrograms/kg doses, was not statistically different from placebo for the primary endpoint.

"These results are surprising and disappointing. While we are still planning to analyze the data from the second phase 3 trial ULISES 008, which we expect by the end of the second quarter, we are stopping all other NDA activities for ulimorelin," said Vipin K. Garg, Ph.D., President and Chief Executive Officer, Tranzyme Pharma.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Google's artificial intelligence or AI player AlphaGo defeated world's number one Go player Ke Jie of China. Go is an ancient Chinese board game, harder than chess. In a fresh crackdown on Uber, Hong Kong police have arrested 21 drivers of the ride-hailing service for illegally carrying passengers without proper permits in the Asian city. The drivers, 20 men and one woman between the ages of 21 and 59, were arrested in an undercover operation by the police for illegally carrying passengers for hire without proper vehicle hire permits. Online retail giant Amazon.com has given out more than 1.7 million free bananas at its Community Banana Stands in downtown Seattle, altering local banana sales, the Wall Street Journal reported. The company, which opened its first Community Banana Stand in late 2015 with idea from founder and CEO Jeff Bezos, has installed two banana stands at its Seattle headquarters.
comments powered by Disqus
Follow RTT